Rallybio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	25.39	27.2	18.74	7.67	6.28
Research & Development	53.54	40.69	26.91	17.63	11.37
Operating Expenses	78.93	67.88	45.65	25.3	17.64
Operating Income	-78.93	-67.88	-45.65	-25.3	-17.64
Interest Expense / Income	0	0	0.01	0.05	0.04
Other Expense / Income	-4.37	-1.23	1.36	1.11	-0.12
Pretax Income	-74.56	-66.65	-47.01	-26.46	-17.56
Income Tax	0	0	0	-0.02	0
Net Income	-74.56	-66.65	-47.01	-26.45	-17.56
Shares Outstanding (Basic)	40	32	26	17	2
Shares Outstanding (Diluted)	40	32	26	17	2
Shares Change	27.11%	24.70%	46.76%	913.79%	-
EPS (Basic)	-1.84	-2.09	-1.84	-1.52	-10.24
EPS (Diluted)	-1.84	-2.09	-1.84	-1.52	-10.24
Free Cash Flow	-60.28	-57.34	-45.87	-22.18	-15.21
Free Cash Flow Per Share	-1.49	-1.80	-1.80	-1.27	-8.87
EBITDA	-74.41	-66.49	-46.89	-26.35	-17.5
Depreciation & Amortization	0.15	0.17	0.11	0.06	0.03
EBIT	-74.56	-66.65	-47	-26.41	-17.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).